Roundtable Discussion: Let’s Talk About Toxicity, Safety, & the Hippo Pathway
Time: 3:00 pm
day: Conference Day Two
Details:
- How do we create meaningful clinical safety endpoints?
- How are we testing compound safety versus target safety?
- Can we produce safe combination therapies?
